Sign in

Alexander C. Razavi

@alexrazavi.bsky.social
312 followers 189 following 1 posts

Cardiology fellow and clinician scientist with a special focus in preventive cardiology #Emory #CiccaroneCenter

PostsRepliesMedia
Reposted by Alexander C. Razavi
Prof. Maciej Banach @maciejbanach.bsky.social · 29/06/2025
‼️The most read paper in 2025: 2024: The Year in #Cardiovascular #Disease - The Year of Lipoprotein(a) #LPA – Research Advances and New Findings. @rblument1.bsky.social @alexrazavi.bsky.social www.archivesofmedicalscience.com/2024-The-Yea...
archivesofmedicalscience.com
2024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings.
Elevated plasma lipoprotein(a) [Lp(a)] levels, which occur in as many as 1.5 billion people worldwide, are an independent and causal risk factor for atherosclerotic cardiovascular disease and calcific...
175
Reposted by Alexander C. Razavi
Harpreet Bhatia @hsbhatia.bsky.social · 09/04/2025
Our new review on the evidence for primary prevention aspirin in individuals with elevated Lp(a) is out now. #CardioSky @ucsdcardiology.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social link.springer.com/epdf/10.1007...
02313
Reposted by Alexander C. Razavi
Parham Eshtehardi MD @cardioobdoc.bsky.social · 12/01/2025
Allocation of #Semaglutide According to #CAC & BMI: Applying the SELECT Trial to MESA #CardioSky #MedSky #JACCIMG www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social @alexrazavi.bsky.social @michaeldshapiro.bsky.social @rblument1.bsky.social @hopkinsheart.bsky.social @erinmichos.bsky.social
088
Reposted by Alexander C. Razavi
Parham Eshtehardi MD @cardioobdoc.bsky.social · 03/12/2024
Traditional Risk Factors, Optimal CV Health & Elevated Lipoprotein(a) #CardioSky #MedSky #EJPC @alexrazavi.bsky.social @hsbhatia.bsky.social academic.oup.com/eurjpc/advan...
0148
Reposted by Alexander C. Razavi
Harpreet Bhatia @hsbhatia.bsky.social · 03/12/2024
In our new study in EJPC, optimal CVD risk factor control was a/w lower risk across Lp(a) levels, though residual risk remains. These results show the importance of aggressive risk factor mgmt in patients with elevated Lp(a). @alexrazavi.bsky.social academic.oup.com/eurjpc/advan...
193
Reposted by Alexander C. Razavi
Parham Eshtehardi MD @cardioobdoc.bsky.social · 25/11/2024
Polygenic Risk Scores & Extreme #CAC Phenotypes in Adults ≥75 Years Old: ARIC Study #Circulation #CardioSky #YesCCT @pnatarajanmd.bsky.social @erinmichos.bsky.social @ahascience.bsky.social @ahajournals.bsky.social @alexrazavi.bsky.social www.ahajournals.org/doi/10.1161/...
0104